A. Peter Passmore

1.6k total citations · 1 hit paper
27 papers, 1.2k citations indexed

About

A. Peter Passmore is a scholar working on Psychiatry and Mental health, Pharmacology and Geriatrics and Gerontology. According to data from OpenAlex, A. Peter Passmore has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 7 papers in Pharmacology and 6 papers in Geriatrics and Gerontology. Recurrent topics in A. Peter Passmore's work include Pharmaceutical Practices and Patient Outcomes (6 papers), Dementia and Cognitive Impairment Research (5 papers) and Alzheimer's disease research and treatments (4 papers). A. Peter Passmore is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (6 papers), Dementia and Cognitive Impairment Research (5 papers) and Alzheimer's disease research and treatments (4 papers). A. Peter Passmore collaborates with scholars based in United Kingdom, Ireland and Greece. A. Peter Passmore's co-authors include Pasquale Calabrese, Josef Kessler, Renee L. Smith, Elke Kalbe, Matthias Brand, R. Morris Bullock, GD Johnston, Carmel Hughes, Carole Parsons and Heather E. Barry and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, Journal of Alzheimer s Disease and British Journal of Clinical Pharmacology.

In The Last Decade

A. Peter Passmore

25 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia

2004 551 citations Elke Kalbe, Josef Kessler et al. International Journal of Geriatric Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Peter Passmore United Kingdom	14	346	200	175	175	120	27	1.2k
Fadi Massoud Canada	19	599 1.7×	212 1.1×	110 0.6×	307 1.8×	131 1.1×	31	1.2k
Serge Gauthier Canada	10	650 1.9×	178 0.9×	136 0.8×	278 1.6×	66 0.6×	15	1.1k
P. L. J. Dautzenberg Netherlands	13	524 1.5×	99 0.5×	99 0.6×	120 0.7×	107 0.9×	32	1.0k
Jenny McCleery United Kingdom	20	513 1.5×	233 1.2×	131 0.7×	331 1.9×	141 1.2×	35	1.6k
Joyce Y.C. Chan Hong Kong	20	679 2.0×	205 1.0×	168 1.0×	158 0.9×	47 0.4×	40	1.4k
Allison Caban‐Holt United States	20	401 1.2×	195 1.0×	138 0.8×	319 1.8×	63 0.5×	58	1.3k
Jean‐François Dartigues France	14	447 1.3×	194 1.0×	164 0.9×	206 1.2×	45 0.4×	24	1.2k
Peter Dal‐Bianco Austria	26	634 1.8×	309 1.5×	84 0.5×	337 1.9×	121 1.0×	75	1.5k
Cyrille P. Launay Canada	23	675 2.0×	130 0.7×	259 1.5×	150 0.9×	47 0.4×	83	1.6k
Sang Joon Son South Korea	19	340 1.0×	195 1.0×	124 0.7×	263 1.5×	47 0.4×	113	1.2k

Countries citing papers authored by A. Peter Passmore

Since Specialization

Citations

This map shows the geographic impact of A. Peter Passmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Peter Passmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Peter Passmore more than expected).

Fields of papers citing papers by A. Peter Passmore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Peter Passmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Peter Passmore. The network helps show where A. Peter Passmore may publish in the future.

Co-authorship network of co-authors of A. Peter Passmore

This figure shows the co-authorship network connecting the top 25 collaborators of A. Peter Passmore. A scholar is included among the top collaborators of A. Peter Passmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Peter Passmore. A. Peter Passmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barry, Heather E., Laura Elizabeth Bedford, Cristín Ryan, et al.. (2020). Improving medicines management for people with dementia in primary care: a qualitative study of healthcare professionals to develop a theory-informed intervention. BMC Health Services Research. 20(1). 120–120. 19 indexed citations

Barry, Heather E., Cristín Ryan, A. Peter Passmore, et al.. (2020). ‘I just take them because I know the people that give them to me’: A theory‐informed interview study of community‐dwelling people with dementia and carers' perspectives of medicines management. International Journal of Geriatric Psychiatry. 36(6). 883–891. 5 indexed citations

Ryan, Michael P., et al.. (2020). Anticholinergic drug use and risk of mortality for people with dementia in Northern Ireland. Aging & Mental Health. 25(8). 1475–1482. 12 indexed citations

Barry, Heather E., Cristín Ryan, A. Peter Passmore, et al.. (2019). Perspectives of community-dwelling people with dementia and their carers about medicines management: a qualitative study. Research Portal (Queen's University Belfast). 2 indexed citations

McGuinness, Bernadette, Marc Fuchs, Suzanne Barrett, A. Peter Passmore, & Janet Johnston. (2015). Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study. Journal of Alzheimer s Disease. 49(4). 1095–1103. 10 indexed citations

Williams, Michael, et al.. (2014). The Prevalence of Age-Related Macular Degeneration in Alzheimer's Disease. Journal of Alzheimer s Disease. 42(3). 909–914. 39 indexed citations

Barry, Heather E., Carole Parsons, A. Peter Passmore, & Carmel Hughes. (2012). An exploration of nursing home managers' knowledge of and attitudes towards the management of pain in residents with dementia. International Journal of Geriatric Psychiatry. 27(12). 1258–1266. 53 indexed citations

Neville, Charlotte E., Michelle C. McKinley, Carole Lowis, et al.. (2012). Encouraging behaviour change in mild cognitive impairment patients: development of educational material. Proceedings of The Nutrition Society. 71(OCE2).

Parsons, Carole, Carmel Hughes, A. Peter Passmore, & Kate L. Lapane. (2010). Withholding, Discontinuing and Withdrawing Medications in Dementia Patients at the End of Life. Drugs & Aging. 27(6). 435–449. 66 indexed citations

10.

McGuinness, Bernadette, Suzanne Barrett, David Craig, John T. Lawson, & A. Peter Passmore. (2010). Attention deficits in Alzheimer's disease and vascular dementia. Journal of Neurology Neurosurgery & Psychiatry. 81(2). 157–159. 59 indexed citations

11.

Kalbe, Elke, Josef Kessler, Pasquale Calabrese, et al.. (2004). DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. International Journal of Geriatric Psychiatry. 19(2). 136–143. 551 indexed citations breakdown →

12.

Dynan, Kevin, et al.. (1998). An elderly man with an irritable hip. Postgraduate Medical Journal. 74(875). 547–548.

13.

Passmore, A. Peter, et al.. (1993). Short Comunication: A Comparison of Agiolax and Lactulose in Elderly Patients with Chronic Constipation. Pharmacology. 47(1). 249–252. 37 indexed citations

14.

McElnay, James C., et al.. (1992). Steady state pharmacokinetic profile of indomethacin in elderly patients and young volunteers. European Journal of Clinical Pharmacology. 43(1). 77–80. 2 indexed citations

15.

Passmore, A. Peter, et al.. (1991). The Antihypertensive and Metabolic Effects of Low and Conventional Dose Cyclopenthiazide in Type II Diabetics with Hypertension. QJM. 12 indexed citations

16.

Passmore, A. Peter, S. Copeland, & GD Johnston. (1990). The effects of ibuprofen and indomethacin on renal function in the presence and absence of frusemide in healthy volunteers on a restricted sodium diet.. British Journal of Clinical Pharmacology. 29(3). 311–319. 18 indexed citations

17.

Passmore, A. Peter, et al.. (1989). Comparison of the acute renal and peripheral vascular responses to frusemide and bumetanide at low and high dose.. British Journal of Clinical Pharmacology. 27(3). 305–312. 16 indexed citations

18.

Johnston, GD & A. Peter Passmore. (1989). The effects of cilazapril alone and in combination with frusemide in healthy subjects.. British Journal of Clinical Pharmacology. 27(S2). 235S–242S. 11 indexed citations

19.

Copeland, Susan E., et al.. (1988). A double-blind cross-over study of nifedipine retard in patients with Raynaud's phenomenon. Clinical Rheumatology. 7(3). 359–365. 6 indexed citations

20.

Passmore, A. Peter, et al.. (1987). Renal and cardiovascular effects of caffeine: A dose–response study. Clinical Science. 72(6). 749–756. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact